We are pleased to announce that the Precision Cancer Medicine (PCM) has received its 2022 CiteScore: 0.8, ranking 344 out of 495 journals in the Surgery category.
With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to fully implement the transparent peer review (TPR) process for all new submission from March 15, 2023.
The Belt and Road International Forum for Precision Radiation Oncology is organized by Fudan University Shanghai Cancer Center and Shanghai Anticancer Association and to be held online during 29 – 31 March 2023.
Welcome to join us at the 18th St. Gallen International Breast Cancer Conference 2023, Vienna, Austria, 15 - 18 March!
The 18th St. Gallen International Breast Cancer Conference 2023 will be held in Vienna, Austria this year during 15-18 March.
We are pleased to present the 2022 Annual Report of Precision Cancer Medicine (PCM).
We are glad to share with you that select PCM content is now available in Chinese
We are glad to present a brief report on the progress of Precision Cancer Medicine (PCM) in 2021
Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Precision Cancer Medicine (PCM) is among the list of COPE membership.
On June 26, 2021, we received the good news from Elsevier that Precision Cancer Medicine (PCM) has been accepted for inclusion in Scopus.
As we prepare this brief 2020 annual report of Precision Cancer Medicine (PCM), the world is still in the fight against COVID-19 pandemic that has gravely impacted every aspects of our personal and professional lives for over a year.
AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020.
PCM Annual Report (2019)
Precision Cancer Medicine welcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.
PCM Annual Report (2018)
Call for Papers - Focused Issue: Genomic Instability, Clonal Evolution and Oncogenesis
1 - 15 of 15 Items